JP JAZZ PHARMACEUTICALS Trademark Information
Number:
2597796
Words:
JP JAZZ PHARMACEUTICALS
Images:
Kind:
Figurative
Status group:
PENDING
Status code:
Published
Status detail:
Under examination
Priority date:
24 Oct 2025
Lodgement date:
24 Oct 2025
First report date:
04 Dec 2025
Acceptance due date:
04 Mar 2027
Filing date:
24 Oct 2025
Indexing constituents:
JP, JAZZ, PHARMACEUTICALS, =JP, PJ, =PJ, LTR, PP, =PP, P, JJ, =JJ, JClass:
5
Mark categories:
Trademark
Last status check:
2026-07-02 06:45:19
Goods and services:
1) Class: 5Description: Pharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, pain, sleep disorders, narcolepsy, schizophrenia, and for use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders
History and publication details:
1) Date: 2025-12-10
Display name: Customer Amendment Made correspondence sent
2) Date: 2025-12-10
Display name: Owner name details updated
Description: Owner: Jazz Pharmaceuticals, Inc.
Previous details: Owner: Jazz Pharmaceuticals, Inc.
New details: Owner: Jazz Pharmaceuticals, Inc.
3) Date: 2025-12-09
Display name: Amendment to Amend Owner Requested
4) Date: 2025-12-04
Display name: Adverse Report (Examination) correspondence sent
5) Date: 2025-12-04
Display name: IP Right has been Examined
6) Date: 2025-10-29
Display name: Awaiting examination
7) Date: 2025-10-29
Display name: Word and image indexing completed
8) Date: 2025-10-24
Display name: IP Right Filed correspondence sent
9) Date: 2025-10-24
Display name: IP Right Filed Published
10) Date: 2025-10-24
Display name: Status change to Published
11) Date: 2025-10-24
Display name: Minimum Filing Requirements Considered
12) Date: 2025-10-24
Display name: Status change to Filed
13) Date: 2025-10-24
Display name: Status change to Received
14) Date: 2025-10-24
Display name: Trade mark representation updated
15) Date: 2025-10-24
Display name: Application Received
Display name: Customer Amendment Made correspondence sent
2) Date: 2025-12-10
Display name: Owner name details updated
Description: Owner: Jazz Pharmaceuticals, Inc.
Previous details: Owner: Jazz Pharmaceuticals, Inc.
New details: Owner: Jazz Pharmaceuticals, Inc.
3) Date: 2025-12-09
Display name: Amendment to Amend Owner Requested
4) Date: 2025-12-04
Display name: Adverse Report (Examination) correspondence sent
5) Date: 2025-12-04
Display name: IP Right has been Examined
6) Date: 2025-10-29
Display name: Awaiting examination
7) Date: 2025-10-29
Display name: Word and image indexing completed
8) Date: 2025-10-24
Display name: IP Right Filed correspondence sent
9) Date: 2025-10-24
Display name: IP Right Filed Published
10) Date: 2025-10-24
Display name: Status change to Published
11) Date: 2025-10-24
Display name: Minimum Filing Requirements Considered
12) Date: 2025-10-24
Display name: Status change to Filed
13) Date: 2025-10-24
Display name: Status change to Received
14) Date: 2025-10-24
Display name: Trade mark representation updated
15) Date: 2025-10-24
Display name: Application Received
Owner Information
Owner structured address:
3000 El Camino Real 2 Palo Alto Square, Suite 600, Palo Alto, California, UNITED STATES OF AMERICA, Postal Code: 94306
Owner is private:
0
Service Information
Address structured address:
PO Box 16232, Sandringham, Auckland, NEW ZEALAND, Postal Code: 1351
Address is private:
0